| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/30/2009 | WO2009033742A3 Streptococcus pneumoniae vaccines |
| 04/30/2009 | WO2009033670A3 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 04/30/2009 | WO2009032978A3 Compositions and methods for diagnosing and treating urinary tract infections |
| 04/30/2009 | WO2009030780A3 Non-natural proteinaceous scaffold made of three non-covalently associated peptides |
| 04/30/2009 | WO2009030464A3 PRODUCTION AND USE OF VARIANTS OF HUMAN KUNITZ-TYPE PROTEASE INHIBITORS (hKTPI) |
| 04/30/2009 | WO2009027539A3 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
| 04/30/2009 | WO2009026155A3 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
| 04/30/2009 | WO2009025754A3 Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| 04/30/2009 | WO2009022156A3 Peptides for desensibilization against allergens |
| 04/30/2009 | WO2009021956A3 Rapid acting insulin analogues |
| 04/30/2009 | WO2009016326A3 Adeno-associated viral vectors for the expression of dysferlin |
| 04/30/2009 | WO2009006301A4 Protein stabilization |
| 04/30/2009 | WO2008147867A3 Cross-linked collagen and uses thereof |
| 04/30/2009 | WO2008147781A3 Hydrocarbon-producing genes and methods of their use |
| 04/30/2009 | WO2008124165A9 Self-assembling nanoparticle drug delivery system |
| 04/30/2009 | WO2008112017A3 Avian influenza vaccine |
| 04/30/2009 | WO2008036406A3 Compositions and methods related to protein displacement therapy for myotonic distrophy |
| 04/30/2009 | WO2008033987A3 Compositions and methods to prevent cancer with cupredoxins |
| 04/30/2009 | WO2007130073A3 Novel reagents for transfection of eukaryotic cells |
| 04/30/2009 | WO2007120787A3 Methods of treating, diagnosing or detecting cancers associated with liv-1 overexpression |
| 04/30/2009 | WO2007103146A3 Truncated proteins as cancer markers |
| 04/30/2009 | WO2007050554A3 Methods for identifying compounds that modulate phb domain protein activity and compositions thereof |
| 04/30/2009 | WO2007041614A3 Long acting vegf inhibitors and methods of use |
| 04/30/2009 | WO2007005912A3 Compositions for treating wounds and processes for their preparation |
| 04/30/2009 | WO2006138610A3 Interferon-alpha/beta binding fusion proteins and therapeutic uses thereof |
| 04/30/2009 | WO2006124448A3 Reduced risk tobacco products and methods of making same |
| 04/30/2009 | WO2006081301A3 Plant defense signal peptides |
| 04/30/2009 | WO2005120583A3 Method for preventing or treating cardiac hypertrophy |
| 04/30/2009 | WO2005059101A3 Novel sodium channel |
| 04/30/2009 | WO2004098515A3 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090113565 Methods for Detecting Fluorescent Proteins and Animals Having Fluorescent Proteins |
| 04/30/2009 | US20090113563 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor with the use of the same |
| 04/30/2009 | US20090111973 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 04/30/2009 | US20090111972 Novel hemopoietin receptor protein, nr12 |
| 04/30/2009 | US20090111970 used to regulate an immune response in an animal; inhibits TF-1 cell proliferation activity |
| 04/30/2009 | US20090111767 Modulation of insulin like growth factor i receptor expression |
| 04/30/2009 | US20090111766 Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases |
| 04/30/2009 | US20090111754 Selective Inhibitors of Nuclear Factor KappaB Activation and Uses Thereof |
| 04/30/2009 | US20090111753 Nogo-A Polypeptide Fragments, Variant Nogo Receptor-1 Polypeptides, and Uses Thereof |
| 04/30/2009 | US20090111752 Stable Formulation of Modified GLP-1 |
| 04/30/2009 | US20090111750 Keratin derivatives and methods of making the same |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111743 Cysteine-branched heparin-binding growth factor analogs |
| 04/30/2009 | US20090111739 Sugar chain added glp-1 peptide |
| 04/30/2009 | US20090111738 Fibronectin polypeptides and methods of use |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | US20090111176 Trehalose transporter gene and method of introducing trehalose into cells |
| 04/30/2009 | US20090111172 isolated polypeptide is immobilized on an immunosorbent surface of ELISA plate for determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse |
| 04/30/2009 | US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
| 04/30/2009 | US20090111146 Antibody Drug |
| 04/30/2009 | US20090111143 Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium |
| 04/30/2009 | US20090111107 Tumor suppressor gene p33ing2 |
| 04/30/2009 | US20090110700 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 04/30/2009 | US20090110693 Multimeric complexes of antigens and an adjuvant |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | US20090110676 BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders |
| 04/30/2009 | US20090110666 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
| 04/30/2009 | US20090110659 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function |
| 04/30/2009 | DE102007000564A1 Kollagenfibrillenmatrices Kollagenfibrillenmatrices |
| 04/30/2009 | DE102004044429B4 Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor A process for preparing a composition comprising von Willebrand Factor |
| 04/30/2009 | CA2704051A1 Polynucleotides and methods for the improvement of plants |
| 04/30/2009 | CA2703962A1 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 04/30/2009 | CA2703947A1 Therapeutic and diagnostic methods using tim-3 |
| 04/30/2009 | CA2703668A1 Synthetic antigenic peptides and lipopeptides derived from mycobacterium avium subsp. paratuberculosis |
| 04/30/2009 | CA2703614A1 Splice variants of gdnf and uses thereof |
| 04/30/2009 | CA2703544A1 Cytokine muteins |
| 04/30/2009 | CA2703490A1 Regulatory elements associated with cbf transcription factor of rye |
| 04/30/2009 | CA2703482A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/30/2009 | CA2703368A1 New antiviral peptides which prevent the binding of the virus to dlc8 |
| 04/30/2009 | CA2703259A1 Identification of tumor-associated markers for diagnosis and therapy |
| 04/30/2009 | CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | CA2703113A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 04/30/2009 | CA2703111A1 Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins |
| 04/30/2009 | CA2703066A1 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| 04/30/2009 | CA2702637A1 Fully human anti-vegf antibodies and methods of using |
| 04/30/2009 | CA2702635A1 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies |
| 04/30/2009 | CA2702623A1 Use of tenascin-w as a biomarker for colon cancer |
| 04/30/2009 | CA2702508A1 Complexes of trpc domains and sestd1 domains and methods and uses involving the same |
| 04/30/2009 | CA2702502A1 Sdf-1-based glycosaminoglycan antagonists and methods of using same |
| 04/30/2009 | CA2702448A1 Method for purifying fc-fusion proteins |
| 04/30/2009 | CA2702333A1 Anti-ricin antibody |
| 04/30/2009 | CA2701802A1 Compositions for detecting antibodies to babesia microti and methods of use thereof |
| 04/30/2009 | CA2701283A1 Methods and compositions for obtaining high-resolution crystals of membrane proteins |
| 04/30/2009 | CA2700522A1 Novel hiv targets |
| 04/30/2009 | CA2696160A1 Pegylation by the dock and lock (dnl) technique |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2053135A1 Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/29/2009 | EP2053126A1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 04/29/2009 | EP2053125A1 Streptococcus pyogenes antigens |
| 04/29/2009 | EP2053124A2 Recombinant RSV virus expression systems and vaccines |
| 04/29/2009 | EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/29/2009 | EP2053060A1 SDF-1-based glyocosaminoglycan antagonists and methods of using same |
| 04/29/2009 | EP2053059A1 Complexes of TRPC domains and SESTD1 domains and methods and uses involving the same |
| 04/29/2009 | EP2053058A1 Attenuation of bacterial virulence |
| 04/29/2009 | EP2053057A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmantal stress |
| 04/29/2009 | EP2053056A1 Dendrimeric peptide construct for the prevention of foot-and-mouth disease in animals |
| 04/29/2009 | EP2052737A1 Synthetic antigenic peptides and lipopeptides derived from mycobacterium avium subsp. paratuberculosis |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |